[Detection of CPS1 gene mutation in a neonate with carbamoyl phosphate synthetase I deficiency]

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Dec 10;35(6):848-851. doi: 10.3760/cma.j.issn.1003-9406.2018.06.017.
[Article in Chinese]

Abstract

Objective: To explore the genetic basis for a neonate featuring hyperammonemia.

Methods: The patient was examined and tested by tandem mass spectrometry and next generation sequencing (NGS). Suspected mutations were confirmed by Sanger sequencing of the proband and her parents. Potential impact of the mutation was predicted with SIFT, PolyPhen-2 and MutationTaste software.

Results: Plasma ammonia and alanine were significantly increased in the proband, while serum citrulline was decreased. The neonate was found to harbor compound heterozygous mutations of the CPS1 gene [c.1631C>T(p.T544M) and c.1981G>T(p.G661C)], which were respectively inherited from her father and mother.

Conclusion: The carbamoyl phosphate synthetase I deficiency of the proband can probably be attributed to the mutations of the CPS1 gene. Above finding has expanded the spectrum of CPS1 mutations in association with carbamoyl phosphate synthetase I deficiency.

MeSH terms

  • Carbamoyl-Phosphate Synthase (Ammonia) / genetics*
  • Carbamoyl-Phosphate Synthase I Deficiency Disease / genetics*
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Hyperammonemia / diagnosis*
  • Hyperammonemia / genetics*
  • Infant, Newborn
  • Mutation

Substances

  • CPS1 protein, human
  • Carbamoyl-Phosphate Synthase (Ammonia)